Your session is about to expire
← Back to Search
Anxiety Skills Training for Anxiety
N/A
Waitlist Available
Led By Robyn L. Shepardson, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age >=18 years
Be older than 18 years old
Must not have
Current (past 2 weeks) severe depressive symptoms (>= 20 on PHQ9)
Diagnosis of Obsessive-Compulsive Disorder (OCD) or serious mental illness (SMI, i.e., psychotic disorders, bipolar disorder) in Problem List
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 weeks, 8 weeks, 12 weeks, post-assessment (16 weeks), follow-up assessment (28 weeks)
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether a brief anxiety treatment is more effective at reducing anxiety symptoms and impairment in Veterans compared to usual care.
Who is the study for?
This trial is for Veterans aged 18 or older who have been seen at Syracuse or Western New York VA primary care clinics in the last year and are experiencing significant anxiety symptoms. It's not open to those with severe communication barriers, cognitive impairments that prevent informed consent, certain mental health diagnoses like OCD or SMI, current intensive psychotherapy for anxiety/depression, recent changes in psychotropic medications, severe depression, or PTSD.
What is being tested?
The study compares a brief behavioral treatment called Veterans Anxiety Skills Training (VAST), which includes up to six 30-minute sessions focused on cognitive-behavioral skills tailored for Veterans' needs against usual care. The effectiveness of VAST will be measured by looking at the severity of anxiety symptoms and functional impairment before and after treatment.
What are the potential side effects?
Since VAST is a non-medication intervention focusing on teaching coping skills for anxiety management rather than using drugs, it may not have typical drug side effects. However, discussing emotional topics during therapy could temporarily increase distress.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently experiencing severe depression.
Select...
I have been diagnosed with OCD or a serious mental illness.
Select...
I am able to understand and consent to the study on my own.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 4 weeks, 8 weeks, 12 weeks, post-assessment (16 weeks), follow-up assessment (28 weeks)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 weeks, 8 weeks, 12 weeks, post-assessment (16 weeks), follow-up assessment (28 weeks)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Overall Anxiety Severity and Impairment Scale change
Secondary study objectives
Depression Anxiety Stress Scale-21 change
Other study objectives
Columbia-Suicide Severity Rating Scale change
Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form change
Sheehan Disability Scale change
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention conditionExperimental Treatment1 Intervention
Modular cognitive-behavioral anxiety intervention tailored to and personalized for Veterans
Group II: Control conditionActive Control1 Intervention
Usual care anxiety treatment
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,668 Previous Clinical Trials
3,765,689 Total Patients Enrolled
17 Trials studying Anxiety
1,884 Patients Enrolled for Anxiety
Robyn L. Shepardson, PhDPrincipal InvestigatorSyracuse VA Medical Center, Syracuse, NY
1 Previous Clinical Trials
35 Total Patients Enrolled
1 Trials studying Anxiety
35 Patients Enrolled for Anxiety
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I was diagnosed with PTSD or screened positive for it in the last 2 years.I am currently in therapy for anxiety or depression.I have recently started or changed my anxiety or depression medication.I am currently experiencing severe depression.I have been diagnosed with OCD or a serious mental illness.I am able to understand and consent to the study on my own.I have significant anxiety symptoms recently.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention condition
- Group 2: Control condition
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.